Newsletter Subject

Youth Social Media Warning; Powassan Virus Death; Cancer Warnings on Alcohol Labels

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Sat, May 27, 2023 11:19 AM

Email Preheader Text

Weekly Review Saturday, May 27, 2023 THE BREAK ROOM CME SPOTLIGHT WORDOSIS ADVERTISEMENT CME SPOTLIG

[MEDPAGE TODAY]( Weekly Review Saturday, May 27, 2023 [Youth Social Media Warning; Powassan Virus Death; Cancer Warnings on Alcohol Labels]( [Real-World Data on COPD Combo Inhalers Favor LAMA-LABAs]( [Sexual Behavior Journal Under Fire Over Gender Dysphoria Paper]( THE BREAK ROOM [Wordectomy: Guess Today’s Medical Condition]( CME SPOTLIGHT [Leveraging Expert-Informed Adverse Event Management and Supportive Care Strategies to Improve Patient Outcomes in Bladder Cancer]( [Memory Boosted With Daily Multivitamins]( [FDA Approves First Oral Antiviral Drug for COVID-19]( WORDOSIS [Play Today's Wordosis: Our Medical Word Game]( ADVERTISEMENT [What to Know About Hank Green's Hodgkin's Lymphoma Diagnosis]( CME SPOTLIGHT [Integrating Novel Classes of Immunotherapy Into Treatment Paradigms in Advanced/Metastatic Melanoma]( [Chronic Pain Detected in the Brain for the First Time]( [Neurologic Events After COVID-19 Vaccines Assessed]( [Earlobe Clip-On Attenuates POTS]( CME SPOTLIGHT [Utilizing Evidence-Based and Guideline-Informed Approaches to Improve TNBC Care]( [Long COVID Now Has a Framework to Define It]( [Farxiga's Decongestion Flop; Benefit of Strong Legs; 2,500-Mile Heart Transport]( [How Black Americans Lost 80 Million Years of Life Over the Past Two Decades]( CME SPOTLIGHT [Immunotherapy in Advanced Melanoma: Evidence-Based Adverse Event Management Strategies to Improve Patient Outcomes]( [Burn Victim Pics Shared? Foreign Botox Settlement; Defibrillator Fire Death Lawsuit]( [In a Reminder of AI's Limits, ChatGPT Fails Gastro Exam]( [Ketamine Matches 'Gold Standard' in Major Depression Trial]( CME SPOTLIGHT [Integrating the Latest Evidence into Patient-Centered Treatment for Advanced/Metastatic Triple Negative Breast Cancer]( [Another Texas Hospital Under Investigation for Youth Gender-Affirming Services]( [Gait Predicts Cognitive Disorders; Diet and MS Relapses; Alzheimer's Drug Protests]( [A COVID Test Medicare Scam May Be a Trial Run for Further Fraud]( CME SPOTLIGHT [Incorporating Recent Data Into Current Treatment Paradigms in Melanoma]( [The Art of Leaving Medicine]( [The Danger of Binary Thinking in Mental Health Care]( [The Opioid Treatment Dilemma in Jails]( CME SPOTLIGHT [Evidence-Based Strategies to Improve Outcomes for Patients With Gastroesophageal Cancers]( [What Our Patients With Dense Breasts Deserve to Know]( [Family Gun Culture May Play a Role in Teens' Risk of Firearm Suicide]( [Dual Phosphodiesterase Inhibitor Improved Lung Function in COPD Patients]( CME SPOTLIGHT [Expert Approaches to the Treatment and Management of Cytomegalovirus (CMV) in Transplant Recipients]( [Medical Board Reprimands Indiana Doctor in Child Abortion Case]( [Dual-Chamber Leadless Pacemaker Impresses in Safety-and-Performance Study]( [Economic Impact of Racial Health Inequities; Obesity and Cancer Risk]( [Can 'Survivor' Teach Us Something About Health and Weight Loss?]( Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [SEE ALL STORIES >]( Got a news tip? MedPage Today offers several ways to provide information to our journalists securely and confidentially. [LEARN MORE >]( [EVERYDAY HEALTH]( © 2023 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_DHE_Weekly?xid=nl_mpt_DHE_2023-05-27&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011

Marketing emails from medpagetoday.com

View More
Sent On

26/06/2024

Sent On

26/06/2024

Sent On

26/06/2024

Sent On

25/06/2024

Sent On

25/06/2024

Sent On

24/06/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2024 SimilarMail.